Please enable JS


Medical News – Positive impact: When considering ‘biosimilars’ legislation, Kentucky must ensure patient safety.

Mar 11/50SN Staff/ GHLF in the news

The positive impact of biologic medicines for the treatment of many chronic diseases, such as multiple sclerosis, HIV, hepatitis C, Rheumatoid arthritis and others, cannot be understated.  That’s why it’s good news that soon patients and prescribers will have access to cutting edge medicines called biosimilars. Read More


LA Times: FDA approves knockoff of Amgen’s Neupogen chemo recovery drug

Mar 10/50SN Staff/ Advocates in the news

Mariah Leach, 32, a Colorado woman who uses biologics to treat rheumatoid arthritis, said she hopes pharmacies and insurers don’t force her to take a biosimilar version. “The opportunity to have a less expensive treatment option is fabulous,” she said. “I just don’t want to be put on it without my choice. I don’t want […]


USA Today: ‘Biosimilar’ drugs could save patients, USA billions

Mar 06/50SN Staff/ Advocates in the news GHLF in the news

In a move expected to increase competition and lower drug prices, the Food and Drug Administration today approved the first “biosimilar” drug, designed to closely mimic existing drugs grown in living cells. Pharmaceutical companies have been able to produce low-cost generic drugs for three decades, but they haven’t before been able to produce knockoff versions […]


CDC’s Advisory Committee for Immunization Practices (ACIP) outcome

Feb 26/50SN Staff/ Letters and Testimony

Victory! CDC’s Advisory Committee for Immunization Practices (ACIP) voted unanimously to recommend the Meningitis B vaccine for at risk populations. In June, the panel will evaluate broader recommendation for college students. Seth had the honor of reading the comments prepared by Neal Raisman, who unfortunately had to return home to Columbus, and was not able […]


Utah HB 279 passes Health and Human Services Committee

Feb 23/50SN Staff/ Letters and Testimony

Listen to Representative Dee (bill sponsor) highlight the power and importance of the patient perspective in his final comments here           Click Here to listen to the interview on Healthy Biologics Transcript: “I did not ask for, nor did I know, that the witness Tabatha Yager would be here today. But I […]